Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laurence Valeyrie-Allanore

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
La Revue Du Praticien|June 13, 2008
[Phacomatosis]Laurence Valeyrie-Allanore, Pierre Wolkenstein
European Journal of Dermatology : EJD|August 4, 2007
Denominations and classification of severe cutaneous adverse reactions to drugs: splitters versus mergersLaurence Valeyrie-Allanore, Jean-Claude Roujeau
Hepatology (Baltimore, Md.)|June 11, 2013
Unusual oral mucosa damage during telaprevir treatment of chronic hepatitis CVasily Isakov, Sergey Morozov, Laurence Valeyrie-Allanore
Drug Safety|November 2, 2007
Drug-induced skin, nail and hair disordersLaurence Valeyrie-Allanore, Bruno Sassolas, Jean-Claude Roujeau
Archives of Dermatology|January 20, 2010
Combined treatment with rituximab and anthracycline-containing chemotherapy for primary cutaneous large B-cell lymphomas, leg type, in elderly patientsAlexis Guyot, Nicolas Ortonne, Laurence Valeyrie-Allanore, et al.
European Journal of Dermatology : EJD|January 19, 2007
Association of hypogammaglobulinemia with DRESS (Drug Rash with Eosinophilia and Systemic Symptoms)Olivia Boccara, Laurence Valeyrie-Allanore, Béatrice Crickx, et al.
Lancet (London, England)|May 7, 2017
Severe cutaneous adverse reactions to drugsTu Anh Duong, Laurence Valeyrie-Allanore, Pierre Wolkenstein, et al.
La Revue Du Praticien|December 2, 2015
[DRUG INDUCED EXANTHEMA AND SEVERE CUTANEOUS DRUG REACTIONS]Benoît Bensaïd, Laurence Valeyrie-Allanore, Bénédicte Lebrun-Vignes, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 23, 2015
Fatal toxic epidermal necrolysis in a patient on teriflunomide treatment for relapsing multiple sclerosisGaspard Gerschenfeld, Amandine Servy, Laurence Valeyrie-Allanore, et al.
Orphanet Journal of Rare Diseases|February 5, 2020
Neurofibromatosis 1 French national guidelines based on an extensive literature review since 1966Christina Bergqvist, Amandine Servy, Laurence Valeyrie-Allanore, et al.
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
La Revue Du Praticien|June 13, 2008
[Phacomatosis]Laurence Valeyrie-Allanore, Pierre Wolkenstein
European Journal of Dermatology : EJD|August 4, 2007
Denominations and classification of severe cutaneous adverse reactions to drugs: splitters versus mergersLaurence Valeyrie-Allanore, Jean-Claude Roujeau
Hepatology (Baltimore, Md.)|June 11, 2013
Unusual oral mucosa damage during telaprevir treatment of chronic hepatitis CVasily Isakov, Sergey Morozov, Laurence Valeyrie-Allanore
Drug Safety|November 2, 2007
Drug-induced skin, nail and hair disordersLaurence Valeyrie-Allanore, Bruno Sassolas, Jean-Claude Roujeau
Archives of Dermatology|January 20, 2010
Combined treatment with rituximab and anthracycline-containing chemotherapy for primary cutaneous large B-cell lymphomas, leg type, in elderly patientsAlexis Guyot, Nicolas Ortonne, Laurence Valeyrie-Allanore, et al.
European Journal of Dermatology : EJD|January 19, 2007
Association of hypogammaglobulinemia with DRESS (Drug Rash with Eosinophilia and Systemic Symptoms)Olivia Boccara, Laurence Valeyrie-Allanore, Béatrice Crickx, et al.
Lancet (London, England)|May 7, 2017
Severe cutaneous adverse reactions to drugsTu Anh Duong, Laurence Valeyrie-Allanore, Pierre Wolkenstein, et al.
La Revue Du Praticien|December 2, 2015
[DRUG INDUCED EXANTHEMA AND SEVERE CUTANEOUS DRUG REACTIONS]Benoît Bensaïd, Laurence Valeyrie-Allanore, Bénédicte Lebrun-Vignes, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 23, 2015
Fatal toxic epidermal necrolysis in a patient on teriflunomide treatment for relapsing multiple sclerosisGaspard Gerschenfeld, Amandine Servy, Laurence Valeyrie-Allanore, et al.
Orphanet Journal of Rare Diseases|February 5, 2020
Neurofibromatosis 1 French national guidelines based on an extensive literature review since 1966Christina Bergqvist, Amandine Servy, Laurence Valeyrie-Allanore, et al.
Pageof 7